StockMarketWire.com - Molecular diagnostics group Yourgene Health said its annual rose 45%, beating market expectations.

Revenue for the year through March jumped to £8.9m, with growth occurring in all active regions, the company said.

International revenue rose 51% to £5.9m, while UK revenues rose 20% to £1.2m/

Test volumes increased 67% to over 82,000.

Cash at year end of £1.25m, up from £0.28m on-year, reflecting continued careful management of working capital, the company said.

'Since joining Yourgene in July 2018, we've made significant commercial progress in our existing markets as well as expanding our footprint to further new territories,' said chief executive Lyn Rees.

'We are also continuing to develop additional products and recently launched our Sage 32 plex test, a new higher throughput NIPT and analysis solution for clinical labs.'

'We have redefined our relationships with Illumina and Thermo Fisher and we are now focused on the significant growth opportunity ahead of us, both within reproductive health and the wider genetic testing landscape.'






Story provided by StockMarketWire.com